[Impact of electronic devices used at an early age on language]. / Impacto del uso de dispositivos electrónicos a edad temprana en el lenguaje.

Background: The acquisition of language in infants is largely the result of the process of brain maturation, as well as environmental stimulation. Currently, society is in an era of technology and use of electronic devices from an early age. Objective: The aim of this study was to demonstrate if the amount of time of use of electronic devices in children under 5 years of age affects language development. Methods: An observational, comparative, survey-type study was carried out in 269 infants of both sexes, with an age range of 6 to <60 months. The language development section of the Child Development Scale (EDI) was used. A logistic regression was performed to determine the strength of association between the factors to be studied. Results: 269 participants were included, of which 224 (83.2%) presented their level of neurological maturation, 44 infants (16.4%) presented laged development and one (0.4%) was classified as having developmental delay. It was found that the number of daily hours that an electronic device is used behaved as a risk factor by increasing the risk of delayed language development by 1.37 times for each hour of exposure (OR: 1.37, CI95%: 1.15-1.62). Conclusions: It was shown that a greater number of hours of use of electronic devices is a risk factor for delayed language development in children under 5 years of age. Therefore, it is vital to limit its use in this population.

Introducción: la adquisición del lenguaje en los infantes es, en gran medida, resultado del proceso de maduración cerebral, así como de la estimulación ambiental. En la actualidad, la sociedad se encuentra en una era de tecnología y uso de dispositivos electrónicos desde temprana edad. Objetivo: evaluar el efecto del tiempo de uso de dispositivos electrónicos en los menores de 5 años en el área del lenguaje. Métodos: se realizó un estudio observacional, comparativo, tipo encuesta, en infantes con rango de edad de 6 a < 60 meses de ambos sexos. Se utilizó la sección para medir desarrollo del lenguaje de la Escala de Desarrollo Infantil (EDI). Adicionalmente, se llevó a cabo una regresión logística con el objetivo de determinar la fuerza de asociación entre los factores a estudiar. Resultados: se incluyeron 269 participantes, de los cuales 224 de ellos (83.2%) correspondían a su nivel de maduración neurológica, 44 infantes (16.4%) presentaron rezago en su desarrollo y uno (0.4%) se clasificó con retraso en el desarrollo. Encontramos que el número de horas diarias utilizando algún dispositivo electrónico se comportó como factor de riesgo, aumentando 1.37 veces el riesgo de retraso en el desarrollo del lenguaje por cada hora de exposición (OR: 1.37, IC95%: 1.15-1.62). Conclusiones: un mayor número de horas de uso de los dispositivos electrónicos es factor de riesgo para presentar retraso en el desarrollo del lenguaje en menores de 5 años.

Extension and Severity of Self-Reported Side Effects of Seven COVID-19 Vaccines in Mexican Population.

A few studies examined the comparative side effects of Coronavirus Disease-19 (COVID-19) vaccines. We compared the extension and severity of self-reported side effects of seven COVID-19 vaccines [BNT162b2 (Pfizer-BioNTech), ChAdOx1 (AstraZeneca), mRNA-1273 (Moderna), CoronaVac (Sinovac Life Sciences), Gam-COVID-Vac (Gamaleya's Sputnik V), Ad5-nCoV (CanSinoBIO), and Ad26.CoV2.S (Johnson & Johnson/Janssen)] in the Mexican population. We also evaluated the association of type of vaccine, sex, age, comorbidity, and history of allergies to the extent and severity of side effects. This was a cross-sectional study carried out online between August 12 and September 3, 2021 in Mexico. The first inclusion criterion was to receive a COVID-19 vaccine and the second, being at least 18 years old. The survey link was distributed via multiple social media platforms. We questioned about the type of vaccine and symptoms based on short-term side effects reported in the literature. Side effect extension was classified as local, systemic, or both. We asked about the need to take medicine, stop activities/miss work, or seek medical attention. Then, a severity index was constructed based on responses. Descriptive and stepwise multivariate logistic ordinal regression analyses were used to calculate odds ratio (OR) and 95% CI for each outcome adjusted by potential confounders. The mean age was 38.9 ± 11.0 years (n = 4,024). Prevalence of at least one side effect varied between vaccines and by a number of doses. At dose 1, ChAdOx1 was the vaccine with the highest rate of at least one side effect (85%) followed by Gam-COVID-Vac (80%). Both were associated to greater extension (adjusted OR 2.53, 95% CI 2.16, 2.96 and adjusted OR 2.41, 95% CI 1.76, 3.29, respectively) and severity of side effects (adjusted OR 4.32, 95% CI 3.73, 5.00 and adjusted OR 3.00, 95% CI 2.28, 3.94, respectively). Young age (<50 years), female sex, comorbidity, and history of allergies were associated with greater extension and severity, independent of the type of vaccine and potential confounders. At dose 2, mRNA-1273 was the vaccine with the highest rate of side effects (88%) and the only vaccine associated to greater extension (adjusted OR 2.88, 95% CI 1.59, 5.21) and severity of symptoms (adjusted OR 3.14, 95% CI 1.82, 5.43). Continuous studies are necessary to acknowledge more post-vaccine symptoms in different populations.

Validación de Shared Decision Making Questionnaire - physician version (SDM-Q-Doc) en español / Validation of the Shared Decision Making Questionnaire - physician version (SDM-Q-Doc) in Spanish

OBJETIVO: Validar Shared Decision Making Questionnaire - physician version (SDM-Q-Doc) en español. DISEÑO: Estudio transversal, multicéntrico y de validación clinimétrica. EMPLAZAMIENTO: Unidades de Atención Primaria. PARTICIPANTES: En la fase de adaptación transcultural fueron 31 médicos de familia y en la de validación 219, todos activos en la práctica médica a nivel institucional y/o privado. MEDICIONES PRINCIPALES: Adaptación transcultural (traducción directa, síntesis y conciliación de la versión por un comité de expertos, traducción inversa, conciliación de la traducción inversa con autores del cuestionario original, análisis de comprensión en una muestra de pacientes) y aspectos psicométricos (fiabilidad y validez). RESULTADOS: Se realizó la adaptación transcultural, la pregunta guía 2 se homologó al SDM-Q-9. No se observaron valores negativos en la correlación de item corregido - con la correlación total; todos son mayores que 0,80. El Alfa de Cronbach fue de 0,963. El item 1 explicó una varianza del 77,2 %. La prueba de Kaiser-Meyer-Olkin (KMO) fue de 0,924 con una esfericidad de Barlett estadísticamente significativa. La matriz de correlación de Pearson demuestra una correlación positiva; en general la relación inter-item es mayor a 0,606. CONCLUSIONES: Se ha validado un cuestionario útil, corto y accesible para aplicarse en Atención Primaria, para medir la toma de decisiones compartidas desde la perspectiva del médico

OBJECTIVE: To validate the Shared Decision Making Questionnaire - physician version (SDM-Q- Doc) in Spanish. DESIGN: Cross-sectional, multicenter, clinimetric validation study. SETTING: Primary Care Units. PARTICIPANTS: In the cross-cultural adaptation phase there were 31 family doctors, and in the validation phase there were 219, all active medical professionals at the institutional and / or private level. MAIN MEASURES: Cross-cultural adaptation (direct translation, synthesis and reconciliation of the version by an expert committee, reverse translation, reconciliation of the reverse translation with authors of the original questionnaire, comprehension analysis in a sample of patients) and psychometric aspects (reliability and validity). RESULTS: Cross-cultural adaptation was performed, guide question 2 was homologated to SDM-Q-9. No negative values were observed in the corrected item-total correlation- with the total correlation; all are higher than 0.80. Cronbach's Alpha was 0.963. Item 1 explained a variance of 77.2%. The Kaiser-Meyer-Olkin (KMO) test was 0.924 with a statistically significant Barlett Sphericity. Pearson's correlation matrix shows a positive correlation; in general the inter-item relationship is greater than 0.606. CONCLUSIONS: A useful, short and accessible questionnaire to be applied in Primary Care has been validated to measure shared decision-making from the physician's perspective

Health care utilization of mexican patients with medically unexplained physical symptoms.

OBJECTIVE: To determine the prevalence of medically unexplained physical symptoms and the characteristics and use of health services in a group of patients with medically unexplained physical symptoms and a group of patients with other illnesses. METHODS: This was a cross-sectional, retrospective and multicenter study. We included 1,043 patients over 18 years of age from 30 primary care units of a government health institution, in 11 states of Mexico, attended by 39 family physicians. The prevalence of medically unexplained physical symptoms was determined and both groups with or without symptoms were compared with regard to drug use, laboratory and other studies, leaves of absence, and referrals in the last six months. The group with medically unexplained physical symptoms was diagnosed using the Patient Health Questionnaire and the diagnostic criteria of Reid et al. Emergency or terminal illnesses were excluded. The chi square test was used with a statistical significance of p < 0.05. RESULTS: Medically unexplained physical symptoms was diagnosed in 73 patients (7.0%). The majority were women (91.8%); their predominant symptom was from the gastrointestinal system in 56 (76.7%). This group had a greater use of clinical studies and referrals to other services (mean 1.1 vs. 0.5; p <0.0001 and 0.6 vs. 0.8; p < 0.01, respectively). CONCLUSIONS: The prevalence of medically unexplained physical symptoms was low, but with a greater impact on some health services. This could represent an overload in medical costs. OBJETIVO: Determinar la prevalencia de Síntomas Físicos Medicamente No Explicables y las características y uso de los servicios de salud entre el grupo de pacientes con Síntomas Físicos Medicamente No Explicables, y el grupo con otras enfermedades. MÉTODOS: Estudio transversal, retroprospectivo y multicéntrico. Se incluyeron a 1,043 pacientes mayores de 18 años, en 30 unidades de atención primaria de una institución gubernamental en salud, en 11 estados de la República Mexicana, atendidos por 39 médicos familiares. Se estimó la prevalencia de Síntomas Físicos Medicamente No Explicables y se compararon los dos grupos con y sin estos síntomas, en cuanto al uso de medicamentos, estudios de laboratorio, de gabinete, incapacidades y referencias en los últimos seis meses. El grupo de Síntomas Físicos Medicamente No Explicables fue diagnosticado por el Patient Health Questionnaire (son los síntomas físicos más comúnmente referidos por estos pacientes en el primer nivel de atención), además de criterios diagnósticos de Reid et al. Se excluyeron urgencias o con enfermedad terminal. Se utilizó prueba Chi cuadrada con p <0.05 para significancia estadística. RESULTADOS: El 7.0% (73) se diagnosticó como Síntomas Físicos Medicamente No Explicables, la mayoría mujeres (91.8%); el síntoma predominante pertenece al sistema gastrointestinal con 76.7% (56). Este grupo demandó mayor uso de estudios de gabinete y referencias a otros servicios (media 1.1 vs. 0.5; p <0.0001 y 0.8 vs 0.6; p <0.01, respectivamente). CONCLUSIONES: La prevalencia de Síntomas Físicos Medicamente No Explicables fue baja, pero con impacto significativo en el uso de algunos servicios de salud. Esto pudiera representar un mayor costo comparado con otro grupo de pacientes.

Health care utilization of mexican patients with medically unexplained physical symptoms / Uso de los servicios de salud de pacientes mexicanos con síntomas físicos medicamente inexplicables

Abstract Objective: To determine the prevalence of medically unexplained physical symptoms and the characteristics and use of health services in a group of patients with medically unexplained physical symptoms and a group of patients with other illnesses. Methods: This was a cross-sectional, retrospective and multicenter study. We included 1,043 patients over 18 years of age from 30 primary care units of a government health institution, in 11 states of Mexico, attended by 39 family physicians. The prevalence of medically unexplained physical symptoms was determined and both groups with or without symptoms were compared with regard to drug use, laboratory and other studies, leaves of absence, and referrals in the last six months. The group with medically unexplained physical symptoms was diagnosed using the Patient Health Questionnaire and the diagnostic criteria of Reid et al. Emergency or terminal illnesses were excluded. The chi square test was used with a statistical significance of p < 0.05. Results: Medically unexplained physical symptoms was diagnosed in 73 patients (7.0%). The majority were women (91.8%); their predominant symptom was from the gastrointestinal system in 56 (76.7%). This group had a greater use of clinical studies and referrals to other services (mean 1.1 vs. 0.5; p <0.0001 and 0.6 vs. 0.8; p < 0.01, respectively). Conclusions: The prevalence of medically unexplained physical symptoms was low, but with a greater impact on some health services. This could represent an overload in medical costs....au

Resumen Objetivo: Determinar la prevalencia de Síntomas Físicos Medicamente No Explicables y las características y uso de los servicios de salud entre el grupo de pacientes con Síntomas Físicos Medicamente No Explicables, y el grupo con otras enfermedades. Métodos: Estudio transversal, retroprospectivo y multicéntrico. Se incluyeron a 1,043 pacientes mayores de 18 años, en 30 unidades de atención primaria de una institución gubernamental en salud, en 11 estados de la República Mexicana, atendidos por 39 médicos familiares. Se estimó la prevalencia de Síntomas Físicos Medicamente No Explicables y se compararon los dos grupos con y sin estos síntomas, en cuanto al uso de medicamentos, estudios de laboratorio, de gabinete, incapacidades y referencias en los últimos seis meses. El grupo de Síntomas Físicos Medicamente No Explicables fue diagnosticado por el Patient Health Questionnaire (son los síntomas físicos más comúnmente referidos por estos pacientes en el primer nivel de atención), además de criterios diagnósticos de Reid et al. Se excluyeron urgencias o con enfermedad terminal. Se utilizó prueba Chi cuadrada con p <0.05 para significancia estadística. Resultados: El 7.0% (73) se diagnosticó como Síntomas Físicos Medicamente No Explicables, la mayoría mujeres (91.8%); el síntoma predominante pertenece al sistema gastrointestinal con 76.7% (56). Este grupo demandó mayor uso de estudios de gabinete y referencias a otros servicios (media 1.1 vs. 0.5; p <0.0001 y 0.8 vs 0.6; p <0.01, respectivamente). Conclusiones: La prevalencia de Síntomas Físicos Medicamente No Explicables fue baja, pero con impacto significativo en el uso de algunos servicios de salud. Esto pudiera representar un mayor costo comparado con otro grupo de pacientes...au